En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 09. December 2022
Urologic Neoplasms
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Musculoskeletal System
Endocrine System
Gynecologic Neoplasms
Respiratory Tract
Urologic Neoplasms
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7505  Previews Next
   Articles 1 - 20 / 150100  
Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial.
Adv Radiat Oncol
Dayes IS, Kennedy AE, Parpia S, Thome C, Tharmalingam S, Lemon JA, Bowdish DME, Boreham DR.
PMID: 36483063 [PubMed - as supplied by publisher]

Role of hydrogel spacer to protect the rectum from thermal injury in focal therapy of prostate cancer: Preclinical study in cadaver model.
Int J Urol
Narukawa T, Fujihara A, Ochiai A, Okihara K, Hongo F, Ukimura O.
PMID: 36482782 [PubMed - as supplied by publisher]

Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis.
Curr Opin Urol
Kawada T, Yanagisawa T, Araki M, Pradere B, Shariat SF.
PMID: 36482766 [PubMed - as supplied by publisher]

"Stromal cells in prostate cancer pathobiology: friends or foes?".
Br J Cancer
Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M.
PMID: 36482187 [PubMed - as supplied by publisher]

Automatic diagnosis and grading of Prostate Cancer with weakly supervised learning on whole slide images.
Comput Biol Med
Xiang J, Wang X, Wang X, Zhang J, Yang S, Yang W, Han X, Liu Y.
PMID: 36481762 [PubMed - as supplied by publisher]

Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
Urol Oncol
Rahman SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, Press BH, Choksi AU, Rajwa P, Pradere B, Ploussard G, Kim JW, Monaghan TF, Renzulli JR, Shariat SF, Leapman MS.
PMID: 36481253 [PubMed - as supplied by publisher]

Effect of Re-TUR time on recurrence and progression in high-risk non-muscle-invasive bladder cancer.
Cir Cir
Demir DO, Doluoglu OG, Yildiz AK, Kacan T, Yazar VM, Demirbas A, Ozgur BC.
PMID: 36480752 [PubMed - as supplied by publisher]

The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.
PLoS One
Karkeet RM, Zekri AN, Sayed-Ahmed MM, Sherif GM, Salem SE, Abdelbary A, Fouad MA, Saad SY.
PMID: 36480560 [PubMed - as supplied by publisher]

The Experiences and Unmet Supportive Care Needs of Partners of Men Diagnosed With Prostate Cancer: A Meta-aggregation Systematic Review.
Cancer Nurs
Roberts C, Toohey K, Paterson C.
PMID: 36480350 [PubMed - as supplied by publisher]

Unamplified and Real-Time Label-Free miRNA-21 Detection Using Solution-Gated Graphene Transistors in Prostate Cancer Diagnosis.
Adv Sci (Weinh)
Deng M, Ren Z, Zhang H, Li Z, Xue C, Wang J, Zhang D, Yang H, Wang X, Li J.
PMID: 36480308 [PubMed - as supplied by publisher]

Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis.
Cancer Med
Ding L, Wang X, Deng X, Xia W, Wang K, Yu X, Huang Y, Wang J.
PMID: 36479836 [PubMed - as supplied by publisher]

Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Cancer Med
Li S, Wang Y, Hu X.
PMID: 36479835 [PubMed - as supplied by publisher]

Oncologic Impact of Cystoscopic Findings in Non-Muscle Invasive Bladder Cancer: A Meta-analysis.
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Sari Motlagh R, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Majdoub M, Pradere B, Abufaraj M, Moschini M, Karakiewicz PI, Iwatani K, Miki J, Kimura T, Shariat SF.
PMID: 36479820 [PubMed - as supplied by publisher]

Optimization of first-line systemic therapy in patients with advanced clear cell renal cell carcinoma.
Int J Urol
Takagi T.
PMID: 36479730 [PubMed - as supplied by publisher]

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Front Immunol
Zhang C, Li Y, Qian J, Zhu Z, Huang C, He Z, Zhou L, Gong Y.
PMID: 36479115 [PubMed - as supplied by publisher]

The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia.
Front Oncol
Xiao Y, Yang J, Yang M, Len J, Yu Y.
PMID: 36479065 [PubMed - as supplied by publisher]

The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic.
Mol Biol Rep
Sehn F, Büttner H, Godau B, Müller M, Sarcan S, Offermann A, Perner S, Kramer MW, Merseburger AS, Roesch MC.
PMID: 36478297 [PubMed - as supplied by publisher]

Radiotherapy for ductal carcinoma of the prostate: an analysis based on the Japanese radiation oncology study group survey.
Jpn J Clin Oncol
Kawamura H, Nakamura K, Yoshioka Y, Itasaka S, Tomita N, Onishi M, Iwata H, Aizawa T, Kikuchi K, Nagata K, Nakamura K, Nishioka K, Ishiyama H, Ueno S, Kokubo M, Yamazaki H, Watanabe K, Toyoda T, Akimoto T, JROSG Working Subgroup of Urologic Oncology.
PMID: 36478251 [PubMed - as supplied by publisher]

Novel cryotherapy in non-muscle-invasive bladder cancer.
Ho MD, Modi PK.
PMID: 36477685 [PubMed - as supplied by publisher]

Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer.
Sci Rep
Yoo JW, Koo KC, Chung BH, Lee KS.
PMID: 36477667 [PubMed - as supplied by publisher]

   Articles 1 - 20 / 150100    Page 1 of 7505  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1